Treatment
Treatment
Advertisement
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | October 21, 2024
Understanding critical symptoms in the “CRAB” acronym can enable oncology nurses to educate patients and caregivers.
Read More
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Multiple Myeloma | October 21, 2024
Up to 50% of patients have renal insufficiency at the time of multiple myeloma diagnosis.
Cecilia BrownGI Cancer | October 18, 2024
The FDA also approved the VENTANA CLDN18 RxDx Assay as a companion diagnostic device.
Cecilia BrownGI Cancer | October 17, 2024
Kohei Shitara, MD, unpacks the SPOTLIGHT and GLOW data behind the approval.
Cecilia BrownBreast Cancer | October 10, 2024
The study analyzed quality-adjusted time without symptoms of disease progression or toxicity of treatment, known as Q-TWiST.
Cecilia BrownBreast Cancer | October 10, 2024
A randomized study is evaluating a nurse-led educational intervention on physical activity for patients with breast cancer.
Amanda Brink, DNP, APRN, FNP-BC, AOCNPTreatment | October 9, 2024
Patients who received the vaccine within 100 days of starting an immune checkpoint inhibitor showed improved survival.
Cecilia BrownGU Cancer | September 30, 2024
The first-of-its kind clinical trial was presented at the 2024 ASTRO Annual Meeting.
Cecilia BrownGU Cancer | September 27, 2024
The study investigators say the 5-year survival rate "dramatically exceeds historical standards."
Leah LawrenceGyn-Onc | September 25, 2024
A long-term study points to the importance of evaluating risks and benefits with estrogen versus progesterone with estrogen.
Leah LawrenceGyn-Onc | September 26, 2024
Patients receiving the antibody-drug conjugate showed a 30% reduction in the risk of death compared with chemotherapy.
Leah LawrenceGyn-Onc | September 25, 2024
A new study is shedding light on post-treatment experiences, with many saying they felt they were "left to themselves."
Amanda Brink, DNP, APRN, FNP-BC, AOCNPGI Cancer | September 20, 2024
Oncology nurses can play a key role in improving outcomes and quality of life for patients with metastatic pancreatic cancer.
Katie KoskoGyn-Onc | September 16, 2024
An interim analysis of part 2 of the RUBY trial showed that dostarlimab plus chemotherapy lowered the risk of death by 31%.
Katie KoskoTreatment | September 12, 2024
Learn what a team of researchers found about the impact of this practice.
Prithviraj Bose, MDConferences | September 13, 2024
Dr. Bose shared his insights at the Twelfth Annual Society of Hematologic Oncology Meeting in Houston.
Cancer Nursing Today EditorsGVHD | September 10, 2024
A new study highlights the importance of effective management and close monitoring of GVHD.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | August 22, 2024
It's critical for oncology nurses understand and recognize the 3 atypical lung cGVHD conditions.
Katie KoskoGVHD | August 20, 2024
A small study evaluated the ROCK2 inhibitor for treatment of ocular GVHD because corneal epithelial cells express ROCK2.
Olivia ThomasBreast Cancer | August 19, 2024
Researchers explored the relationship between post-traumatic growth and perceived stress in this population of patients.
Advertisement
Advertisement
Advertisement